Targeting Notch in oncology: the path forward

S Majumder, JS Crabtree, TE Golde… - Nature Reviews Drug …, 2021 - nature.com
Notch signalling is involved in many aspects of cancer biology, including angiogenesis,
tumour immunity and the maintenance of cancer stem-like cells. In addition, Notch can …

Therapeutics of Alzheimer's disease: Past, present and future

R Anand, KD Gill, AA Mahdi - Neuropharmacology, 2014 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors

HO Tayeb, HD Yang, BH Price, FI Tarazi - Pharmacology & therapeutics, 2012 - Elsevier
Alzheimer's disease (AD) is the most common cause of memory impairment and dementia in
the elderly. AD is pathologically characterized by extracellular deposits of beta-amyloid (Aβ) …

The γ-secretase complex: from structure to function

X Zhang, Y Li, H Xu, Y Zhang - Frontiers in cellular neuroscience, 2014 - frontiersin.org
One of the most critical pathological features of Alzheimer's disease (AD) is the
accumulation of β-amyloid (Aβ) peptides that form extracellular senile plaques in the brain …

Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology

V Frisardi, F Panza, D Seripa, T Farooqui… - Progress in lipid …, 2011 - Elsevier
An increasing body of evidence suggested that intracellular lipid metabolism is dramatically
perturbed in various cardiovascular and neurodegenerative diseases with genetic and …

Notch signaling, hypoxia, and cancer

M Guo, Y Niu, M Xie, X Liu, X Li - Frontiers in Oncology, 2023 - frontiersin.org
Notch signaling is involved in cell fate determination and deregulated in human solid
tumors. Hypoxia is an important feature in many solid tumors, which activates hypoxia …

[HTML][HTML] Focus: the aging brain: amyloid-beta Alzheimer targets—protein processing, lipid rafts, and amyloid-beta pores

M LaFontaine, M Cumbay - The Yale journal of biology and …, 2016 - ncbi.nlm.nih.gov
Amyloid beta (Aβ), the hallmark of Alzheimer's Disease (AD), now appears to be deleterious
in its low number aggregate form as opposed to the macroscopic Aβ fibers historically seen …

A molecular history of the amyloidoses

JN Buxbaum, RP Linke - Journal of molecular biology, 2012 - Elsevier
The molecular investigation of the amyloidoses began in the mid-19th century with the
observation of areas in human tissues obtained at autopsy that were homogeneous and …

Solanezumab for the treatment of mild-to-moderate Alzheimer's disease

BP Imbimbo, S Ottonello, V Frisardi… - Expert review of …, 2012 - Taylor & Francis
Solanezumab (LY2062430) is a humanized monoclonal antibody that binds to the central
region of β-amyloid, a peptide believed to play a key role in the pathogenesis of Alzheimer's …

Plasma amyloid beta measurements-a desired but elusive Alzheimer's disease biomarker

JB Toledo, LM Shaw, JQ Trojanowski - Alzheimer's research & therapy, 2013 - Springer
Cerebrospinal fluid and positron emission tomography biomarkers accurately predict an
underlying Alzheimer's disease (AD) pathology; however, they represent either invasive or …